SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clarification from Sun Pharma Advanced Research Company

05 Oct 2015 Evaluate

With reference to the news articles published in the media (including The Economic Times dated September 28, 2015), where the Company - Sun Pharma Advanced Research Company Limited (‘SPARC’) has been mentioned as a subsidiary of Sun Pharmaceutical Industries Limited (‘SPIL’), In this regard, Sun Pharma Advanced Research Company has clarified that while both SPARC & SPIL have a common Promoter ‘Dilip Shanghvi’ and accordingly forms a part of the same Group, there is no ‘Subsidiary -Holding Company’ relationship between the two Companies.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

144.55 -3.35 (-2.27%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 436.55
Indegene 482.65
CMS Info Systems 317.60
JITF Infralogistics 331.25
Sagility 42.17
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×